Avg closing price
Price range

13 Ken Griffin Trillium Therapeutics Trades

The first Trillium Therapeutics trade was made in Q4 2017. Since then Ken Griffin bought shares five more times and sold shares on seven occasions. The investor completely sold their stake between Q3 2021 and Q4 2021.

Avg closing price
Price range
Sold -799 Thousand shares Q4 2021
Avg closing price $17.82
Price range $17.50 - $18.44
Sold 80.8% shares (-3.37 Million shares) Q3 2021
Avg closing price $11.68
Price range $5.86 - $17.80
Increased shares by 18.6% (+655 Thousand shares) Q2 2021
Avg closing price $9.41
Price range $7.48 - $11.18
Sold 6.2% shares (-231 Thousand shares) Q1 2021
Avg closing price $12.37
Price range $9.86 - $15.51
Increased shares by 16.2% (+521 Thousand shares) Q3 2020
Avg closing price $9.97
Price range $6.56 - $16.00
Sold 6.4% shares (-221 Thousand shares) Q2 2020
Avg closing price $6.19
Price range $3.53 - $9.43
New holding (+3.44 Million shares) Q1 2020
Avg closing price $3.78
Price range $1.14 - $7.22
Sold -34.9 Thousand shares Q4 2019
Avg closing price $0.38
Price range $0.25 - $1.03
New holding (+34.9 Thousand shares) Q3 2019
Avg closing price $0.34
Price range $0.25 - $0.41
Sold -23.2 Thousand shares Q1 2019
Avg closing price $1.22
Price range $0.60 - $2.00
New holding (+23.2 Thousand shares) Q4 2018
Avg closing price $3.00
Price range $1.65 - $5.65
Sold -24.6 Thousand shares Q1 2018
Avg closing price $7.58
Price range $6.68 - $8.80
New holding (+24.6 Thousand shares) Q4 2017
Avg closing price $8.28
Price range $5.15 - $12.35

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!